Atlas Trials

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

Clinical trial NCT05408910 · WITHDRAWN

Trial details

NCT number
NCT05408910
Sponsor
Wake Forest University Health Sciences
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cystic FibrosisAbdominal PainSmall Bowel Disease
Start date
2025-07-01
Primary completion
2025-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.